G. Gahn et al., Contrast-enhanced transcranial color-coded duplexsonography in stroke patients with limited bone windows, AM J NEUROR, 21(3), 2000, pp. 509-514
Citations number
15
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: Thickening of the temporal bone in stroke-age patie
nts may obviate sonographic evaluation of the circle of Willis in 20% to 30
% of patients. We assessed the diagnostic efficacy of contrast-enhanced tra
nscranial color-coded duplexsonography (TCCD) for noninvasive evaluation of
the circle of Willis in stroke patients with limited bone windows.
METHODS: Of 171 consecutive patients who presented with ischemic symptoms i
n the middle cerebral artery (MCA) territory, 49 patients (32 female, 17 ma
le; age range, 70.5 +/- 10.6 years) had no detectable colorflow signals fro
m the circle of Willis by TCCD because of limited acoustic windows. These 4
9 patients received an IV injection of a sonographic contrast-enhancing age
nt, Levovist (Schering; Berlin, Germany), and were re-examined. Correlative
imaging studies of the circle of Willis were obtained in 42 of 49 of these
patients.
RESULTS: In 38 of 49 patients, contrast-enhanced TCCD enabled full visualiz
ation of the circle of Willis bilaterally; in an additional five patients,
contrast-enhanced TCCD revealed only the portion of the circle of Willis ip
silateral to the probe through one temporal bone. In six of these 43 patien
ts, contrast-enhanced TCCD showed MCA stenosis and MCA occlusion in three;
three of the six cases of MCA stenosis and all three cases of the MCA occlu
sion were found on the symptomatic side, In six of 49 patients, no colorflo
w signals were obtained after contrast enhancement. All contrast-enhanced T
CCD findings were confirmed by CT angiography, transfemoral digital substra
ction angiogaphy, MR angiography, or a combination of all three correlative
studies. Levovist produced no serious adverse events.
CONCLUSION: In stroke-age patients with limited acoustic windows, contrast-
enhancement with Levovist can markedly increase the sensitivity of TCCD and
increase the detection of clinically relevant intracranial arterial diseas
e.